FIELD: medicine, cellular therapy. SUBSTANCE: invention relates to a drug exhibiting the definite composition and quantitative indices of the cellular suspension obtained from native or cryopreserved hemopoietic cells of human embryo liver and/or spleen. Also, invention relates to a method of treatment of patients with AIDS (HIV-infection) by administration of the indicated drug that is taken among the formed tissue bank of different specimens with regard to individual indices of patient being the same preparation is used in repeated administration. EFFECT: broadened pattern of agents for control of HIV-infection. 6 cl, 41 tbl, 7 ex
| Title | Year | Author | Number |
|---|---|---|---|
| CELL SUSPENSION-BASED IMMUNOCORRECTING DRUG AND USING THIS DRUG IN A METHOD OF TREATING DIABETES MELLITUS | 1994 |
|
RU2126260C1 |
| METHOD FOR TREATING PATIENTS WITH EMBRYONIC CELLULAR SUSPENSIONS | 1998 |
|
RU2226104C2 |
| BIOMEDICAL CELL PRODUCT FOR TREATING NERVOUS DISEASES AND MENTAL DISORDERS, METHOD FOR PRODUCTION THEREOF AND USE THEREOF | 2018 |
|
RU2720002C1 |
| BIOTRANSPLANT, METHOD FOR ITS OBTAINING (VARIANTS) AND METHOD FOR TREATING PARODONTIUM DISEASES | 2004 |
|
RU2265445C1 |
| BIOMEDICAL CELL PREPARATION | 2017 |
|
RU2647429C1 |
| AGENT FOR REGULATION OF ENDOGENOUS PRODUCTION OF CYTOKINE AND HEMOPOIETIC FACTOR (VARIANTS) AND METHOD OF ITS USING | 1996 |
|
RU2153351C2 |
| BIOMEDICAL CELL PRODUCT FOR THE TREATMENT OF ONCOLOGICAL, NEURODEGENERATIVE, AUTOIMMUNE DISEASES AND INJURIES OF THE BRAIN AND SPINAL CORD | 2021 |
|
RU2798554C2 |
| ANTITUMOR TARGET CELL PRODUCT, METHOD FOR ITS PRODUCTION AND ITS APPLICATION | 2018 |
|
RU2757812C2 |
| BIOTRANSPLANT AND METHOD FOR TREATING THE CASES OF DIABETES MELLITUS OF TYPE I AND II | 2004 |
|
RU2265443C1 |
| METHOD OF TREATMENT OF PATIENT WITH HIV-INFECTION | 1998 |
|
RU2146930C1 |
